SEMAGLUTIDE / START HERE
What Have Studies Found About Semaglutide and GLP-1?
You’ll see evidence on weight, kidneys, the liver, and heart health, and you won’t lose the limits of a large 2025 study.
What’s the plain answer about Semaglutide?
Novo Nordisk changed an older drug so each dose would work longer. Semaglutide copies GLP-1, the name doctors use for a hormone your intestine releases when you eat. It comes as a shot or a tablet. It has roles in type 2 diabetes and weight care, along with some heart risks and the fatty liver illness called MASH since 2025, when the label and your own health allow it. If you were family, I’d start here: a large 2025 liver study helped roughly 6 of 10 people. Nausea, weight regain, and risks from compounded drugs still matter; the effects page explains them. The large studies used approved medicine, not a product mixed by a compounding pharmacy.
What did the largest Semaglutide studies find?
Semaglutide acts like GLP-1, a hormone your intestine releases when you eat. Its 31-amino-acid chain is made from small protein parts. Your own GLP-1 fades fast, but semaglutide stays for nearly a week. The GLP-1 shot and tablet work on different timetables, and they won’t suit everyone.
In 2025, a phase-3 study checked liver harm with a biopsy, which is a small tissue sample. Each person got a 2.4 mg weekly shot or a placebo, which held no semaglutide. Swelling ended without worse scars in 62.9% on semaglutide and 34.3% on placebo. Scars eased without worse swelling in 36.8% on semaglutide and 22.4% on placebo [1].
In STEP 1, researchers studied adults without diabetes. By week 68, average weight changed -14.9% with a 2.4 mg shot and -2.4% with placebo [2]. SUSTAIN-6 found fewer heart deaths, nonfatal heart attacks, and nonfatal strokes among people with type 2 diabetes who took semaglutide [3]. Its 95% check is meant to show how much the answer may shift by chance; even then, the finding didn’t flip against the drug. Another study followed 17,604 adults and found 20% fewer such heart events. Its 95% check also favored semaglutide [4].
Kidney researchers followed 3,533 people with kidney disease and type 2 diabetes. In that study, the major kidney event count was 24% lower with a 1.0 mg amount; its 95% check favored semaglutide [5]. Here’s the part that matters: these gains don’t erase nausea or weight regain, and they don’t prove anything about a compounded product.
Why does Semaglutide last for a week?
Semaglutide was built to act like GLP-1, a hormone from your intestine. Its parts are about 94% the same. What’s useful to you is that the drug lasts far longer than your own hormone.
Lab papers number the three changes 8, 34, and 26. You don’t need those lab numbers to follow what the drug does. One change slows DPP-4, the lab name for an enzyme that removes the hormone. Its full name, dipeptidyl peptidase-4, won’t help you make a choice. Another change lets semaglutide ride through your blood on a protein. Read what is semaglutide, how does semaglutide work, Semaglutide research, or Semaglutide references for the part you need.
Why isn’t compounded Semaglutide the same?
The large studies used approved medicine made under set factory rules. From roughly 2022 to early 2025, shortage rules let compounding pharmacies prepare semaglutide. The FDA later reported dose mistakes, hospital stays, and ingredients that lacked proper checks. That temporary allowance wasn’t proof of equal quality.
In early 2025, federal officials closed most of the broad shortage allowance. Compounded products didn’t appear in the main studies, leaving more doubt about quality and safety. On Semaglutide effects, you’ll find study results kept apart from personal accounts. You won’t find a seller chosen for you here.